Washington, D.C. 20549 _________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-Q _________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _______ to _______ Commission file number 1-12383 _______________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2026 Commission file number: 1-10110 BANCO BILBAO VIZCAYA ARGENTARIA, S.A. (Exact name of Registrant as specified in its charter) BANK BILBAO VIZCAYA ARGENTARIA, S.A. (Translation of Registrant's name into English) Calle Azul, 4 28050 Madrid Spain (Address of principal executive offices) Indica ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 28, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37502 MASTERCRAFT BOAT HOLDINGS, INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction (I.R.S. Emplo ...

Financial Performance - Revenues decreased by $0.7 million, or 0.3%, to $261.2 million for the three months ended December 31, 2025, compared to $261.9 million for the same period in 2024[115] - Gross profit increased by $4.6 million to $161.7 million, with a gross profit margin of 61.9%, up from 60.0% in the prior year[117] - Operating income surged by $54.6 million to $83.3 million, compared to $28.7 million in the previous year[117] - Net income reached $44.1 million, a significant increase from $0.0 million in the prior year[117] - Cost of products sold decreased by $5.3 million, or 5.1%, to $99.5 million, representing 38.1% of revenues, down from 40.0%[118] - Selling and administrative expenses fell by $3.5 million, or 4.3%, to $77.6 million, primarily due to lower compensation expenses[119] - Research and development expenses dropped by $15.7 million, or 77.3%, to $4.6 million, reflecting the discontinuation of the insulin patch pump program[120] Debt and Liquidity - As of December 31, 2025, Embecta's total principal debt issued amounted to $1,379.3 million, with long-term debt at $1,352.9 million after accounting for current debt obligations and issuance costs[128][130] - Embecta's total debt as of December 31, 2025, was $1,362.4 million, with short-term debt constituting 0.7% of total debt and a weighted average cost of total debt at 6.1%[128] - The company made interest payments of $13.2 million on outstanding debt during the three months ended December 31, 2025, and paid approximately $37.5 million on the Term Loan, of which $35.1 million was discretionary[130] - Cash and equivalents, along with restricted cash, decreased to $204.4 million as of December 31, 2025, down from $228.6 million as of September 30, 2025, primarily due to financing activities[138] - The company maintains sufficient liquidity through cash, cash equivalents, and borrowing capacity to meet operational and growth needs[127] - The effective tax rate decreased to 25.1% from 100.0% in the prior year, due to changes in earnings mix and lower limitations on interest expense deductibility[126] Operational Risks and Challenges - Future cash flows and financial performance are subject to various risks, including competitive factors and the ability to replace services currently provided by BD[147] - Operating costs have increased due to new tariffs imposed by the U.S. and foreign governments, affecting raw materials and energy costs[149] - The company faces risks from the global trade environment, with potential shifts in customer preferences towards local products due to tariffs[149] - Changes in reimbursement practices and foreign currency exchange rates could adversely impact financial performance[149][150] - Interest rate risk is primarily related to the Term Loan, with a potential $6.8 million impact on interest expense from a 100 basis point change in rates[153] - The impact of geopolitical instability and pandemics on operations and supply chains remains a concern for the company[149] Strategic Initiatives - The company is focused on the expected benefits of its Separation from BD and the associated risks of dis-synergy costs[149] - There are risks related to the completion of strategic partnerships and acquisitions that could accelerate growth and access to new technologies[149] - The company is undergoing a Patch Pump Program Restructuring Plan and a 2025 Restructuring Plan, with expectations on costs and profitability[149] - The ability to obtain FDA clearance for new products is critical for the company's future business decisions and market success[149] - The company has entered into foreign currency forward exchange contracts to manage currency exposure, which helps offset gains and losses[151][152] Credit Ratings and Compliance - Embecta's credit ratings were reaffirmed by Moody's at B1 and by Standard & Poor's at B+ in early 2026[136] - The company is in compliance with all financial covenants related to its credit agreements as of December 31, 2025[128]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the prece ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 28, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to______ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | Commission File No. | Name of Registrant, State of Incorporation, Address of Principal Offices, and Telephone No. | IRS Employer I ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM __________ TO ________ COMMISSION FILE NUMBER 001-34295 SIRIUS XM HOLDINGS INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpo ...

Exhibit 99.1 NEWS RELEASE Construction Partners, Inc. Announces Fiscal 2026 First Quarter Results Revenue Up 44% Compared to Q1 FY25 Adjusted Net Income Up 99% Compared to Q1 FY25 Adjusted EBITDA Up 63% Compared to Q1 FY25 Record Backlog of $3.09 Billion Company Raises FY26 Outlook DOTHAN, AL, February 5, 2026 – Construction Partners, Inc. (NASDAQ: ROAD) ("CPI" or the "Company"), a vertically integrated civil infrastructure company specializing in the construction and maintenance of roadways in local market ...

Exhibit 99.1 ● Third quarter net sales of $461.6 million increased 17.0% over last year, Aerospace/Defense up 41.5% and Industrial up 3.1%. ● Gross margin of 44.3% for the third quarter of fiscal 2026 compared to 44.3% last year; Adjusted gross margin of 45.1% compared to 44.3% last year. ● Third quarter net income attributable to common stockholders as a percentage of net sales of 14.6% vs 14.4% last year; Adjusted EBITDA as a percentage of net sales of 32.4% vs 31.1% last year. ● Free cash flow of $99.1 m ...

Exhibit 99.1 News Release Magnera Reports First Quarter Results First Quarter Highlights Curt Begle, Magnera's CEO, commented: "Magnera delivered a strong first quarter that met our expectations and reinforces our full-year 2026 Adjusted EBITDA and free cash flow guidance. These results reflect the continued focus and execution of our teams across the organization. Capital allocation remains disciplined and aligned with our commitment to debt reduction. During the quarter, we made $27 million in debt paymen ...